Evidence map›Paper›PMID 30808982›Full record

ArticleScientific reports2019

Differential expression of a prophage-encoded glycocin and its immunity protein suggests a mutualistic strategy of a phage and its host.

Emma L Denham, Sjouke Piersma, Marleen Rinket, Ewoud Reilman, Marcus C de Goffau, Jan Maarten van Dijl

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. The genome ofFrontiers in microbiology · 2023
    Article
  3. Article
  4. Article
  5. The life cycle of SPβ and related phages.Archives of virology · 2021
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Emma L DenhamUniversity of Groningen, University Medical Center Groningen, Department of Medical Microbiology, Hanzeplein 1, P.O. Box 30001, 9700 RB, Groningen, The Netherlands.
Sjouke PiersmaUniversity of Groningen, University Medical Center Groningen, Department of Medical Microbiology, Hanzeplein 1, P.O. Box 30001, 9700 RB, Groningen, The Netherlands.
Marleen RinketUniversity of Groningen, University Medical Center Groningen, Department of Medical Microbiology, Hanzeplein 1, P.O. Box 30001, 9700 RB, Groningen, The Netherlands.
Ewoud ReilmanUniversity of Groningen, University Medical Center Groningen, Department of Medical Microbiology, Hanzeplein 1, P.O. Box 30001, 9700 RB, Groningen, The Netherlands.
Marcus C de GoffauUniversity of Groningen, University Medical Center Groningen, Department of Medical Microbiology, Hanzeplein 1, P.O. Box 30001, 9700 RB, Groningen, The Netherlands.
Jan Maarten van DijlUniversity of Groningen, University Medical Center Groningen, Department of Medical Microbiology, Hanzeplein 1, P.O. Box 30001, 9700 RB, Groningen, The Netherlands. j.m.van.dijl01@umcg.nl.
University Medical Center Groningen · NLUniversity of Groningen · NL

Funding

DISEASE PREVENTION ANALYSIS OF INTESTINAL METAPLASIAF06TW002008 · FIC · UNIVERSITY OF ARIZONA · PI AICKIN, MIKEL G · 1994 to 1994
–
6 · The paper itself

Abstract

Sublancin 168 is a highly potent and stable antimicrobial peptide secreted by the Gram-positive bacterium Bacillus subtilis. Production of sublancin gives B. subtilis a major competitive growth advantage over a range of other bacteria thriving in the same ecological niches, the soil and plant rhizosphere. B. subtilis protects itself against sublancin by producing the cognate immunity protein SunI. Previous studies have shown that both the sunA gene for sublancin and the sunI immunity gene are encoded by the prophage SPβ. The sunA gene is under control of several transcriptional regulators. Here we describe the mechanisms by which sunA is heterogeneously expressed within a population, while the sunI gene encoding the immunity protein is homogeneously expressed. The key determinants in heterogeneous sunA expression are the transcriptional regulators Spo0A, AbrB and Rok. Interestingly, these regulators have only a minor influence on sunI expression and they have no effect on the homogeneous expression of sunI within a population of growing cells. Altogether, our findings imply that the homogeneous expression of sunI allows even cells that are not producing sublancin to protect themselves at all times from the active sublancin produced at high levels by their isogenic neighbors. This suggests a mutualistic evolutionary strategy entertained by the SPβ prophage and its Bacillus host, ensuring both stable prophage maintenance and a maximal competitive advantage for the host at minimal costs.

Indexed as

SymbiosisBacillus subtilisBacterial ProteinsBacteriocinsEscherichia coliGene Expression Regulation, BacterialGene Expression Regulation, ViralGlycopeptidesProphagesTranscriptional ActivationTranscription FactorsViral ProteinsBacterial ProteinsBacteriocinsGlycopeptidessublancin 168Transcription FactorsViral Proteins

Identifiers

PMID30808982
PMCPMC6391423
OpenAlexW2920038971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.